A detailed history of Sherbrooke Park Advisers LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 15,245 shares of STTK stock, worth $16,769. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,245
Holding current value
$16,769
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $4.85 $45,735 - $73,938
15,245 New
15,245 $53.2 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.